Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma

被引：0
|
作者：
Semra Paydas
Ali Ogul
Cem Irili
Serkan Gokcay
机构：
[1] Cukurova University Faculty of Medicine,Department of Medical Oncology
来源：
Annals of Hematology | 2016年 / 95卷
关键词：
Neuropathy; Peripheral Neuropathy; Dose Adjustment; Hodgkin Lymphoma; Bendamustine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：145 / 146
页数：1
相关论文
共 50 条
  • [21] Toxicities of Brentuximab Vedotin in Children and Adolescents with Hodgkin Lymphoma
    Titapiwatanakun, Ruetima
    Batth, Sukhjeet Singh
    Baker, Katherine
    Tcheng, Wendy
    Fernandez, Karen S.
    BLOOD, 2019, 134
  • [22] A safety evaluation of brentuximab vedotin for the treatment of Hodgkin lymphoma
    Oak, Eunhye
    Bartlett, Nancy L.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (06) : 875 - 882
  • [23] The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma
    Lai, Catherine
    Kandahari, Adrese Michael
    Ujjani, Chaitra
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2019, 9 : 63 - 71
  • [24] Safe prolonged use of brentuximab vedotin in a patient with Classical Hodgkin Lymphoma on hemodialysis
    Schad, Aimee
    Pakanati, Abhinandan R.
    Woelich, Susan
    Chilkulwar, Abhishek
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2023, 11
  • [25] USE OF BRENTUXIMAB VEDOTIN TO TREAT HODGKIN LYMPHOMA IN A PRIVATE SECTOR SETTING IN BRAZIL
    Andrade, F.
    Barreto, T.
    Zagadailov, E.
    Gautam, A.
    Clark, O. A.
    Saad, F.
    Seal, B.
    Dalal, M.
    Baiocchi, O.
    VALUE IN HEALTH, 2017, 20 (09) : A878 - A878
  • [26] Brentuximab vedotin for relapsed or refractory Hodgkin's lymphoma
    Chen, Runzhe
    Chen, Baoan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 1729 - 1733
  • [27] Significance of Brentuximab Vedotin in the Treatment of Hodgkin's Lymphoma
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (04) : 230 - 231
  • [28] Update on the role of brentuximab vedotin in classical Hodgkin lymphoma
    Tomassetti, Sarah
    Herrera, Alex F.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (09) : 261 - 272
  • [29] Use of brentuximab vedotin in a 10 year old boy with relapsed Hodgkin's lymphoma - clinical case
    Brito, M.
    Ferreira, I.
    Silva, S.
    Benedito, M.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S367 - S367
  • [30] Brentuximab Vedotin for Stage III or IV Hodgkin's Lymphoma
    Crump, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (16): : 1559 - +
12345